We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UMG:EURONEXT AMSTERDAMUniversal Music Group N.V. Analysis

Data as of 2026-07-08 - not real-time

$21.42

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The share price is trading above its short‑term 20‑day moving average but remains below both the 50‑day and 200‑day averages, indicating a loss of upward momentum. The RSI hovers around the 50‑point midpoint, suggesting neutral pressure, while the MACD histogram is modestly positive yet the overall trend is flagged as bearish and volume is on a downtrend.
Fundamental backdrop: Revenue growth is modest at around 5% with solid gross and operating margins, and ROE exceeds 30%. However, the valuation is stretched – the PE ratio is well above the industry average and the DCF‑derived fair value is far below the current price. A 3% dividend yield is attractive but the payout ratio above 60% combined with a recent €500 million senior note issuance pushes the debt‑to‑equity ratio to a high level, raising sustainability concerns.
Market sentiment and risk: The Fear & Greed index sits in the “Extreme Greed” zone, while 30‑day volatility exceeds 35% and the stock’s beta is below 1, indicating higher price swings with limited market correlation. Historical max drawdown approaching 46% underscores the downside risk despite a strong brand and cash‑flow generation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near resistance with decreasing volume
  • Technical indicators showing mixed but overall bearish bias
  • Elevated valuation relative to peers

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash flow and high ROE supporting earnings stability
  • High leverage after recent debt issuance
  • Dividend yield attractive but payout ratio raises sustainability questions

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Robust brand and diversified music‑rights portfolio
  • Persistent overvaluation versus DCF fair value
  • Potential for improved capital structure if earnings growth accelerates

Key Metrics & Analysis

Financial Health

Revenue Growth5.00%
Profit Margin12.26%
P/E Ratio22.8
ROE33.78%
ROA7.67%
Debt/Equity74.58
P/B Ratio7.5
Op. Cash Flow$1.7B
Free Cash Flow$1.6B
Industry P/E16.1

Technical Analysis

TrendBearish
RSI50.6
Support$20.10
Resistance$21.97
MA 20$20.93
MA 50$21.97
MA 200$23.92
MACDBullish
VolumeDecreasing
Fear & Greed Index89.07

Valuation

Fair Value$12.26
GradeOvervalued
TypeBlend
Dividend Yield3.03%

Risk Assessment

Beta0.79
Volatility35.04%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.